Contact Lens Spectrum

References

July 2013

Document #212

 

 

(p. 16) Research Review – Vision and Dry Eye

By Eric Papas, PhD, MCOptom, DipCL, FAAO

 

1. Reiger G. The importance of the precorneal tear film for the quality of optical imaging. British Journal of Ophthalmology. 1992;76:157-158.

2. Dry eyes and visual acuity. Lancet. 1992;339(8806):1389.

3. Lovie-Kitchin, Jan E. <http://eprints.qut.edu.au/view/person/Lovie-Kitchin,_Jan.html>  & Brown, Brian http://eprints.qut.edu.au/view/person/Brown,_Brian.html>  (2000) Repeatability and Intercorrelations of Standard Vision Tests as a Function of Age. Optometry and Vision Science, 77(8), pp. 412-420.

4. Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. American Journal of Ophthalmology. 2002;133(2):181-186.

5. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of Dry Eye Syndrome on Vision-Related Quality of Life. American Journal of Ophthalmology. 2007;143(3):409-415.e402.

6. Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007). Ocular Surface. 2007;5(2):75-92.

7. Tong L, Waduthantri S, Wong TY, et al. Impact of symptomatic dry eye on vision-related daily activities: The Singapore malay eye study. Eye. 2010;24(9):1486-1491.

8. Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Invest Ophth Vis Sci. 2012;53(9):5722-5727.

9. Le Q, Zhou X, Ge L, Wu L, Hong J, Xu J. Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population. BMC Ophthalmology. 2012;12(1).

10. Wang Y, Xu J, Sun X, Chu R, Zhuang H, He JC. Dynamic wavefront aberrations and visual acuity in normal and dry eyes. Clinical and Experimental Optometry. 2009;92(3):267-273.

11. Denoyer A, Rabut G, Baudouin C. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology. 2012;119(9):1811-1818.

 

 

 

 

(p. 23) CL Design & Materials – Managing Dryness With the Boston Keratoprosthesis

By Ronald K. Watanabe, OD, FAAO, & David Murakami, OD

 

1 and 6: Dohlman C, Dudenhoefer E, Khan B, Morneault S. Protection of the Ocular Surface after Keratoprosthesis Surgery: The Role of Soft Contact Lenses. The CLAO Journal. 28(2): 72-74, 2002

2: Fasolo A, Capuzzo C, Fornea, et al. Risk Factors for graft failure after penetrating keratoplasty: 5-year follow-up from the corneal transplant epidemiological study. Cornea. 2011; 30:1328-1335.

3: Dolhman CH, Waller SG, Netland PA. Keratoprosthesis surgery.  In: Lindquist TD, Linstrom RI, eds. Opthalmic Surgery Update, no 4. Chicago: Mosby-Year Book; 1997:1-31.

4: Kim MJ, Bakhtiari P, Aldave AJ. The International Use of Boston Type I Keratoprosthesis. International Ophthalmology Clinics.  Volume 53, Number 2, 79-89

5 and 7: Harissi-Dagher M. The Role of Soft Contact Lenses as an Adjunct to the Boston Keratoprosthesis. International Ophthalmology Clinics. Vol 48, Number 2, 43-51, 2008

8. Beyer J, Todani A, Dohlman C. Prevention of Visually Debilitating Deposits on Soft Contact Lenses in Keratoprosthesis Patients. Cornea. 2011; 30: 1419-1422

 

 

 

 

(p. 24) Dry Eye Dx and Tx – The Dry Eye Pipeline: What’s in it for Us?

By William Townsend, OD, FAAO

 

1.      Smith JA. Et al. The epidemiology of dry eye disease: Report of the epidemiology subgroup of the international dry eye workshop (2007) The Ocular Surface. 2007;5(2):93-107

2.      INichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA The international workshop on meibomian gland dysfunction: executive summary. nvest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1922-9.

3.      .Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995 Oct;21(4):221-32.

4.      Galor A, Zheng DD, Arheart KL, Lam BL, Perez VL, McCollister KE, Ocasio M, McClure LA, Lee DJ.Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006.Cornea. 2012 Dec;31(12):1403-7

5.      Karpecki PM. Why Dry Eye Trials Often Fail. Review Optom. 2013 January

6.      Clinicaltrials.gov/ct2/results?term=dry+eye

7.      Clinicaltrials.gov/ct2/results?term=dry+eye&pg=3

8.      Philp D, Kleinman HK. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci. 2010 Apr;1194:81-6

9.      Sosne G, Qiu P, Ousler GW 3rd, Dunn SP, Crockford D. Thymosin β4: a potential novel dry eye therapy. Ann N Y Acad Sci. 2012 Oct;1270:45-50.

10.  Sosne G, Christopherson PL, Barrett RP, Fridman R. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2388-95.

11.  clinicaltrials.gov/ct2/show/NCT01670357?term=dry+eye&rank=81

12.  wikipedia.org/wiki/Flavones

13.  Seo MJ, Kim JM, Lee MJ, Sohn YS, Kang KK, Yoo M. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model. Curr Eye Res. 2010 Feb;35(2):165-75

14.  clinicaltrials.gov/ct2/show/study/NCT01850979?term=dry+eye&rank=106

15.  Moscovici BK, Holzchuh R, Chiacchio BB, Santo RM, Shimazaki J, Hida RY. Clinical treatment of dry eye using 0.03% tacrolimus eye drops. Cornea. 2012 Aug;31(8):945-9

16.  Almawi WY, Melemedjian OK. Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A. Nephrol Dial Transplant. 2000 Dec;15(12):1916-8.

 

 

 

 

(p. 25) Contact Lens Care & Compliance – Patient Resources for Dry Eye

By Susan J. Gromacki, OD, MS, FAAO

 

1.      Seltzer ARoncari I, and Garfinkel P.  Effect of patient education on medication compliance.  Canadian Journal of Psychiatry 1980;25(8):638-645.

 

2.      Brus HLM, van de Laar MAFJ, Taal E et al.  Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis.  Ann Rheum Dis 1998;57:146-151 doi:10.1136/ard.57.3.146.

3.      Karpecki P.  The Essential Role of Patient Education in Growing My Practice.  Contact Lens Spectrum, February 2013.  http://www.clspectrum.com/articleviewer.aspx?articleID=107947

 

 

 

(p. 26) Inflammation and Dry Eye: What Do We Know?

By Mile Brujic, OD, & David Kading, OD

 

1.      Paugh JR, Knapp LL, Martinson JR, Hom MM. Meibomian therapy in problematic contact lens wear. Optom Vis Sci. 1990 Nov;67(11):803-6.

2.      Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004 Mar;78(3):409-16.

3.      Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocul Surf. 2004 Apr;2(2):124-30.

4.      Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000 May;118(5):615-21.

5.      McCabe E, Narayanan S. Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry. 2009 Oct;80(10):555-66.

6.      Gumus K, Cavanagh DH. The role of inflammation and anti-inflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol. 2009;3:57-67.

7.      Baudouin C et al.  2007 Report of the International Dry Eye Workshop.  The Ocular Surface. 2007; 5(2): 65-204.

8.      Nichols J. OSD Management Methods to Dye for. Contact Lens Spectrum. 2005; 20(5):

9.      Korb DR, Greiner JV, Herman JP, Hebert E, Finnemore VM, Exford JM, Glonek T, Olson MC. Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J. 2002 Oct;28(4):211-6.

10.  Korb DR, Herman JP, Greiner JV, Scaffidi RC, Finnemore VM, Exford JM, Blackie CA, Douglass T.  Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens. 2005 Jan;31(1):2-8.

11.  Xu KP, Yagi Y, Tsubota K. Decrease in corneal sensitivity and change in tear function in dry eye. Cornea. 1996 May;15(3):235-9.

12.  Bourcier T et al.  Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci. 2005 July; 46(7):2341-5.

13.  http://www.tearlab.com/products/doctors/productinfo.htm

14.  Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005 Sep;31(5):186-93.

15.  Liu H, Begley C, Chen M, Bradley A, Bonanno J, McNamara NA, Nelson JD, Simpson T. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3671-9.

16.  Acera A, Rocha G, Vecino E, Lema I, Durแn JA. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res. 2008 Oct;40(6):315-21.

17.  Chotikavanich S, de Paiva CS, Li de Q, Chen JJ, Bian F, Farley WJ, Pflugfelder SC. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3203-9.

18.  Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2283-92.

19.  http://www.rpsdetectors.com/in/products/inflammadry/about/product-info/

20.  Sambursky R, Davitt WF 3rd, Latkany R, Tauber S, Starr C, Friedberg M, Dirks MS, McDonald M. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013 Jan;131(1):24-8.

21.  Clinical Ocular Pharmacology.  Third Edition. Bartlett Jimmy, Jaanus Siret.  P1013. 303-304.

22.  Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003 Oct;136(4):593-602.

23.  Pflugfelder SC. Anti-inflammatory therapy for dry eye. Am J Ophthalmol. 2004 Feb;137(2):337-42.

24.  Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004 Sep;138(3):444-57.

25.  http://www.allergan.com/assets/pdf/restasis_pi.pdf

26.  Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol. 2002 Mar;120(3):330-7.

27.  Perry HD, Donnenfeld ED. Topical 0.05% cyclosporin in the treatment of dry eye. Expert Opin Pharmacother. 2004 Oct;5(10):2099-107.

28.  Prabhasawat P, Tesavibul N, Mahawong W. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction. Cornea. 2012 Dec;31(12):1386-93.

29.  Foulks GN, Borchman D, Yappert M, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea. 2013 Jan;32(1):44-53.

30.  McDermott AM et al. Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf. 2005 Oct;3(4 Suppl):S131-8.

31.  Yeniad B, Beginoglu M, Bilgin LK. Lid-wiper epitheliopathy in contact lens users and patients with dry eye. Eye Contact Lens. 2010 May;36(3):140-3.

32.  Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1319-28.

33.  Albietz JM. Conjunctival histologic findings of dry eye and non-dry eye contact lens wearing subjects. CLAO J. 2001 Jan;27(1):35-40.

34.  Villani E, Ceresara G, Beretta S, Magnani F, Viola F, Ratiglia R. In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci. 2011 Jul 13;52(8):5215-9.

35.  Liu Q, McDermott AM, Miller WL. Elevated nerve growth factor in dry eye associated with established contact lens wear. Eye Contact Lens. 2009 Sep;35(5):232-7.

36.  Glasson M, Stapleton F, Willcox M. Lipid, lipase and lipocalin differences between tolerant and intolerant contact lens wearers. Curr Eye Res. 2002 Oct;25(4):227-35.

37.  Sarac O, Gurdal C, Bostancı-Ceran B, Can I. Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel. Int Ophthalmol. 2012 Jun;32(3):229-33.

38.  Chen SP, Massaro-Giordano G, Pistilli M, Schreiber CA, Bunya VY. Tear osmolarity and dry eye symptoms in women using oral contraception and contact lenses. Cornea. 2013 Apr;32(4):423-8.

39.  http://solution.biotrue.com/

40.  Campbell R, Kame G, Leach N, Paul M, White E, Zigler L. Clinical benefits of a new multipurpose disinfecting solution in silicone hydrogel and soft contact lens users. Eye Contact Lens. 2012 Mar;38(2):93-101.

41.  Thekveli S et al.  Structure-Property Relationship of delefilcon A Lenses. BCLA. 2012

42.  Pruitt J et al.  Surface Characterization of a Water Gradient Silicone Hydrogel Contact Lens (delefilcon A). ARVO. 2012

43.  Hom MM. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients. Eye Contact Lens. 2006 Mar;32(2):109-11.

44.  Willen CM, McGwin G, Liu B, Owsley C, Rosenstiel C. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes. Eye Contact Lens. 2008 Jan;34(1):43-5.

45.  D'Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Mol Interv. 2002 Feb;2(1):22-35.

46.  Nichols JJ, Bickle KM, Zink RC, Schiewe MD, Haque RM, Nichols KK. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye. Eye Contact Lens. 2012 Mar;38(2):73-9.

47.  Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008 Jun;31(3):141-6.

 

 

 

(p. 34) Dry Eye Technology Update

By Amber Gaume Giannoni, OD, FAAO

 

1.      Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6125-30.

2.      Suzuki M, Massingale ML, Ye F, et al. Tear osmolarity as a biomarker for dry eye disease severity. Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4557-61.

3.      Lemp MA, Baudouin C, et al. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 75-92.

4.      Greiner JV. Effect of single thermal pulsation treatment on clinical signs and symptoms of meibomian gland dysfunction and dry eye over 12 months. Paper presented at the annual American Society of Cataract and Refractive Surgery meeting, March 25-29, 2011; San Diego.

5.      Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive meibomain gland dysfunction. Cornea, 2010 Oct;29(10):1145-52

6.      Toyos, R.  Intense Pulsed Light as a Treatment for Dry-eye Disease due to Meibomian Gland Dysfunction.  Poster presented at the annual Association for Vision Research and Ophthalmology meeting, May 5-9, 2013. Abstract Number: 966 - B0271.

7.      Kent C.  Intense Pulsed Light: For Treating Dry Eye.  Review of Ophthalmology Technology Update.   http://www.revophth.com/content/d/technology_update/c/25857.  Accessed 5/15/2013.

 

 

 

(p. 38) Managing Contact Lens-Related Dry Eye

By Heiko Pult, PhD, MSc, FAAO, FBCLA, FEAAO, & William L. Miller, OD, MS, PhD, FAAO

 

1.      Nichols JJ, Mitchell GL, Nichols KK, Chalmers R, Begley C. The performance of the contact lens dry eye questionnaire as a screening survey for contact lens-related dry eye. Cornea 2002;21:469-75.

2.      Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci 2000;77:40-6.

3.      Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci 2011;47:1319-28.

4.      Richdale K, Sinnott L, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea 2007;26(2):168-74.

5.      Pritchard N. How can we avoid CL drop-outs? Optician 2001;5825:222:14-8.

6.      Pritchard N, Fonn D, Brazeau D. Discontinuation of contact lens wear: a survey. Int Contact Lens Clin 1999;26:157-62.

7.      Evans K, Pult H. How important are surface properties for successful contact lens wear? Optician 2012;5:14-8.

8.      Pult H. Dry eye in soft contact lens wearers. Contact Lens Spectrum 2011;07:26-53.

9.      Sindt CW, Longmuir RA. Contact lens strategies for the patient with dry eye. Ocul Surf 2007;5:294-307.

10.  Giannoni GA, Nichols JJ. 2012 Annual Report on Dry Eye Diseases. Contact Lens Spectrum 2012;27 26-42.

11.  Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA. The International Workshop on Meibomian Gland Dysfunction: Executive Summary. Invest Ophthalmol Vis Sci 2011;52:1922-9.

12.  Giovagnoli D, Graham SJ. Inferior punctal occlusion with removable silicone punctal plugs in the treatment of dry-eye related contact lens discomfort. J Am Optom Assoc 1992;63:481-5.

13.  Ramamoorthy P, Sinnott LT, Nichols JJ. Treatment, material, care, and patient-related factors in contact lens-related dry eye. Optometry And Vision Science 2008;85:764-72.

14.  Craig JP, Purslow C, Murphy PJ, Wolffsohn JS. Effect of a liposomal spray on the pre-ocular tear film. Cont Lens Anterior Eye 2010;33:83-7.

15.  Pult H, Gill F, Riede-Pult BH. Effect of three different liposomal eye sprays on ocular comfort and tear film. Contact Lens and Anterior Eye 2012;89:E1035-41.

16.  Spiteri A, Mitra M, Menon G, Casini A, Adams D, Ricketts C, Hickling P, Fuller ET, Fuller JR. Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjogren's syndrome. J Fr Ophtalmol 2007;30:357-64.

17.  Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T, Rolando M, Tsubota K, Nichols KK. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction. Investigative Ophthalmology & Visual Science 2011;52:2050-64.

18.  Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee. Investigative Ophthalmology & Visual Science 2011;52:1930-7.

19.  King-Smith PE, Fink BA, Nichols JJ, Nichols KK, Braun RJ, McFadden GB. The contribution of lipid layer movement to tear film thinning and breakup. Invest Ophthalmol Vis Sci 2009;50:2747-56.

20.  Pult H, Riede-Pult BH. Non-contact meibography: Keep it simple but effective. Cont Lens Anterior Eye 2012;35:77-80.

21.  Guillon M. Are silicone hydrogel contact lenses more comfortable than hydrogel contact lenses? Eye & Contact Lens 2013;39:86-92.

22.  Schafer J, Mitchell GL, Chalmers RL, Long B, Dillehay S, Barr J, Bergenske P, Donshik P, Secor G, Yoakum J. The stability of dryness symptoms after refitting with silicone hydrogel contact lenses over 3 years. Eye Contact Lens 2007;33:247-52.

23.  Dumbleton KA, Chalmers RL, McNally J, Bayer S, Fonn D. Effect of lens base curve on subjective comfort and assessment of fit with silicone hydrogel continuous wear contact lenses. Optom Vis Sci 2002;79:633-7.

24.  Santodomingo-Rubido J, Rubido-Crespo MJ. The clinical investigation of the base curve and comfort rate of a new prototype silicone hydrogel contact lens. Eye Contact Lens 2008;34:146-50.

25.  Brennan NA. Contact lens-based correlates of soft lens wearing comfort. In: Acadmey 2009. Orlando: American Academy of Optometry; 2009.

26.  Wolffsohn JS, Hunt OA, Chowdhury A. Objective clinical performance of 'comfort-enhanced' daily disposable soft contact lenses. Cont Lens Anterior Eye 2010;33:88-92.

27.  Peterson RC, Wolffsohn JS, Nick J, Winterton L, Lally J. Clinical performance of daily disposable soft contact lenses using sustained release technology. Cont Lens Anterior Eye 2006;29:127-34.

28.  Koh S, Maeda N, Hamano T, Hirohara Y, Mihashi T, Hori Y, Hosohata J, Fujikado T, Tano Y. Effect of internal lubricating agents of disposable soft contact lenses on higher-order aberrations after blinking. Eye & contact lens 2008;34:100-5.

29.  Berry M, Purslow C, Murphy PJ, Pult H. Contact Lens Materials, Mucin Fragmentation and Relation to Symptoms. Cornea 2012;31:770-6.

30.  Pult H, Purslow C, Berry M, Murphy PJ. Clinical tests for successful contact lens wear: relationship and predictive potential. Optom Vis Sci 2008;85:E924-9.

31.  Pult H, Murphy PJ, Purslow C. A Novel Method to Predict Dry Eye Symptoms in New Contact Lens Wearers. Optom Vis Sci 2009;86:E1042-50.

32.  H๖h H, Schirra F, Kienecker C, Ruprecht KW. Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye. Ophthalmologe 1995;92:802-8.

33.  Pult H, Riede-Pult B. Grading of Lid-Parallel Conjunctival Folds by Novice and Experienced Observers. Investigative Ophthalmology & Visual Science 2011;52:3739-.

34.  Pult H, Purslow C, Murphy PJ. The relationship between clinical signs and dry eye symptoms. Eye (Lond) 2011;25:502-10.

35.  Watanabe A, Yokoi N, Kinoshita S, Hino Y, Tsuchihashi Y. Clinicopathologic study of conjunctivochalasis. Cornea 2004;23:294-8.

36.  Wang Y, Dogru M, Matsumoto Y, Ward SK, Ayako I, Hu Y, Okada N, Ogawa Y, Shimazaki J, Tsubota K. The Impact of Nasal Conjunctivochalasis on Tear Functions and Ocular Surface Findings. Am J Ophthalmol 2007;144:930-7 e1.

37.  Pult H, Murphy PJ, Purslow C. A novel method to predict the dry eye symptoms in new contact lens wearers. Optom Vis Sci 2009;86:E1042-50.

38.  Korb DR, Herman JP, Solomon JD, Greiner JV, Blackie CA. Lid Wiper Staining and Sequential Fluorescein Instillation. Invest Ophthalmol Vis Sci 2006;47:ARVO E-Abstract: 242.

39.  Berry M, Pult H, Purslow C, Murphy PJ. Mucins and ocular signs in symptomatic and asymptomatic contact lens wear. Optom Vis Sci 2008;85:E930-8.

40.  Korb DR, Greiner JV, Herman JP, Hebert E, Finnemore VM, Exford JM, Glonek T, Olson MC. Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J 2002;28:211-6.

41.  Korb DR, Herman JP, Greiner JV, Scaffidi RC, Finnemore VM, Exford JM, Blackie CA, Douglass T. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens 2005;31:2-8.

42.  Pult H, Korb DR, Blackie CA, Knop E. About Vital Staining of the Eye and Eyelids. I. The Anatomy, Physiology, and Pathology of the Eyelid Margins and the Lacrimal Puncta by E. Marx. Optom Vis Sci 2010;87:718-24.

43.  Korb DR, Blackie CA. Marx's Line of the Upper Lid is Visible in Upgaze Without Lid Eversion. Eye Contact Lens 2010;36:149-51.

44.  Pult H, Murphy PJ, Purslow C. The longitudinal impact of soft contact lens wear on lid wiper epitheliopathy and lid-parallel conjunctival folds. In: 6th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance. Florence, Italy; 2010.

45.  Lievens CW, Hakim N, Chinn A. The effect of multipurpose solutions on the ocular surface. Eye Contact Lens 2006;32:8-11.

46.  Pult H. The Role of Lens Care Solutions in Contact Lens Comfort. Contact Lens Spectrum 2012;27:33-55.

47.  Efron N, Morgan P. Soft contact lens care regimens in the UK Cont Lens Anterior Eye 2008;31:283-4.

48.  Carnt N, Jalbert I, Stretton S, Naduvilath T, Papas E. Solution toxicity in soft contact lens daily wear is associated with corneal inflammation. Optom Vis Sci 2007;84:309-15.

49.  Dalton K, Subbaraman LN, Rogers R, Jones L. Physical properties of soft contact lens solutions. Optom Vis Sci 2008;85:122-8.

50.  Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern M, Pflugfelder SC. Experimentally induced dry eye produces ocular surface inflammation and epithelial disease. Adv Exp Med Biol 2002;506:647-55.

 

 

 

(p. 42) Assessing End-of-Day Comfort

By Desmond Fonn, Dip Optom, MOptom, FAAO

 

1.      Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol. 2009; 127:1632-9.

2.      Weed K, Fonn D, Potvin R. Discontinuation of contact lens wear. Optom Vis Sci 1993; 70(12s): 140

3.      Pritchard N, Fonn D, Brazeau D. Discontinuation of contact lens wear: A survey. Int Contact Lens Clin 1999; 26:157–162.

4.      Pritchard N, Young G, Coleman S, et al. Prevalence and reasons for contact lens discontinuation in the UK. Cont Lens Anterior Eye 2002; 25:202.

5.      Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea. 2007;26:168–174

6.      Young G, Veys J, Coleman S. A multicentre study of lapsed contact lens wearers. Optom Physiol Opt 2002;22:516–27

7.      Fonn D, Situ P, Simpson TL. Hydrogel lens dehydration and subjective comfort and dryness ratings in symptomatic and asymptomatic contact lens wearers. Optom Vis Sci 1999; 76: 700-704.

8.      Guillon M, Maissa C. Dry eye symptomatology of soft contact lens wearers and non-wearers. Optom Vis Sci 2005; 82:829–34.

9.      Chalmers RL, Begley CG. Dryness symptoms among an unselected clinical population with and without contact lens wear. Contact Lens Anterior Eye 2006; 29:25–30.

10.  Fonn D, Dumbleton KA. Dryness and discomfort with silicone hydrogel contact lenses. Eye & Contact Lens. 2003;29:S101-4.

11.  Dumbleton K, Woods CA, Jones LW, Fonn D. Comfort and adaptation to silicone hydrogel lenses for daily wear.  Eye & Contact Lens. 2008; 34: 215-23.

12.  Glasson MJ, Stapleton F, Keay L, Sweeney D, Willcox MDP. Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers. Invest Ophthalmol Vis Sci 2003; 44:5116-5124.

13.  Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci. 2006; 47:1319-1328.

14.  Young G, Chalmers R, Napier L, Kern J, Hunt C, Dumbleton K. Soft Contact Lens-Related Dryness with and without Clinical Signs. Optom Vis Sci. 2012: 89; 1125-32

15.  Cedarstaff TH, Tomlinson A. A comparative study of tear evaporation rates and water content of soft contact lenses. American Journal of Optometry and Physiological Optics 1983; 60:167-174.

16.  Tomlinson A, Fagehi R, Manahilov V. Why do some contact lens wearers avoid contact lens dry eye syndrome? Optom Vis Sci. 2012; 89: E abstract 120286

17.  Chen Q, Wang J, Shen M, et al.Tear menisci and ocular discomfort during daily contact lens wear in symptomatic wearers. Invest Ophthalmol Vis Sci. 2011;52:2175-80

18.  Kojima T, Matsumoto Y, Ibrahim O, et al. Effect of Controlled Adverse Chamber Environment Exposure on Tear Functions in Silicon Hydrogel and Hydrogel Soft Contact Lens Wearers. Invest Ophthalmol Vis Sci.2011; 52:8811- 8817.

19.  Korb DR, Greiner JV, Herman JP et al. Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J. 2002; 28:211-6.

20.  Pult H, Murphy PJ, Purslow C.A novel method to predict the dry eye symptoms in new contact lens wearers. Optom Vis Sci. 2009;86:1042-50.

21.  Dumbleton K, Woods CA, Jones L et al. The Impact of Contemporary Contact Lenses on Contact Lens Discontinuation. Eye & Contact Lens. 2012 (in press)

22.              Keir N, Richter D, Varikooty J, Jones L, Woods CA, Fonn D. End of day comfort interpreted using a novel cumulative comfort score. Invest Ophthalmol Vis Sci 2012;53: E-Abstract 4728

 

 

(p. 46) Contact Lens Practice Pearls – The Importance of Meibomian Gland Expression

By Gregory J. Nixon, OD, FAAO

 

1.      Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA. The international workshop on meibomian gland dysfunction: Executive Summary. Invest. Ophthalmol. Vis. Sci. 2011;52(4): 1922-1929.

 

2.      Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006-49.

 

 

 

(p. 52) Treatment Plan – Comfortable Wear Despite CLDE

By William L. Miller, OD, MS, PhD, FAAO

 

1.      Korb DR, Herman JP, Blackie CA, et al. Prevalence of lid wiper epitheliopathy in subjects with dry eye signs and symptoms. Cornea 2010;29(4):377-383.

 

2.      Yeniad B, Beginoglu M, Bilgin LK. Lid-wiper epitheliopathy in contact lens users and patients with dry eye.  Eye Contact Lens 2010;36(3):140-143.

 

3.      Pult H, Purslow C, Berry M, Murphy PJ. Clinical tests for successful contact lens wear: relationship and predictive potential. Optom Vis Sci 2008;85(10):E924-E929.

 

4.     McMonnies CW. Incomplete blinking: exposure keratopathy, lid wiper epitheliopathy, dry eye, refractive surgery, and dry contact lenses. Cont Lens Anterior Eye. 2007;30(1):37-51.

 

 

 

End Document #212